Breast Cancer Research Q1 Unclaimed
Breast Cancer Research is a journal indexed in SJR in Oncology and Cancer Research with an H index of 175. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2890 €. The scope of the journal is focused on oncology, breast cancer. It has an SJR impact factor of 2,578 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,578.
Breast Cancer Research focuses its scope in these topics and keywords: breast, cancer, tumor, estrogen, metastasis, receptor, deficiency, current, confer, community, ...
Type: Journal
Type of Copyright: CC BY + CC0
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
2890 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
2,578
SJR Impact factor175
H Index147
Total Docs (Last Year)340
Total Docs (3 years)7128
Total Refs2515
Total Cites (3 years)334
Citable Docs (3 years)5.8
Cites/Doc (2 years)48.49
Ref/DocOther journals with similar parameters
Molecular Cancer Q1
Journal of Thoracic Oncology Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1
Compare this journals
Aims and Scope
Best articles by citations
Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters
View moreJMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer
View moreP8-03: Exact quantification of gene amplification in archival tissue sections by laser-assisted microdissection and real-time PCR
View moreN-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma
View moreCombining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment
View moreFibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor beta1 signaling in metastatic breast cancers
View moreEarly but not late pregnancy induces lifelong reductions in the proportion of mammary progesterone sensing cells and epithelial Wnt signaling
View moreRetinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions
View moreBiopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives
View moreEngagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation
View moreTrastuzumab emtansine: mechanisms of action and drug resistance
View morePost-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice
View moreMalignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells
View moreIdentification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening
View moreOutsmarting cancer: the power of hybrid genomic/proteomic biomarkers to predict drug response
View moreMammographic texture resemblance generalizes as an independent risk factor for breast cancer
View moreA methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue
View morePhase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer
View moreSex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects
View moreVariants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study
View moreAre triple negative tumours and basal-like breast cancer synonymous?
View moreEffects of an exercise and hypocaloric healthy eating intervention on indices of psychological health status, hypothalamic-pituitary-adrenal axis regulation and immune function after early-stage breast cancer: a randomised controlled trial
View moreSmoking at time of diagnosis and breast cancer-specific survival: new findings and systematic review with meta-analysis
View moreBreast tumors from CHEK2 1100delC mutation carriers: genomic landscape and clinical implications
View more
Comments